Eva Acosta Rodriguez

Dr. Eva Acosta Rodriguez

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2007 in Nature Immunology
Verified
Journal Article
Closed access
EREva Acosta Rodriguez
Eva Acosta Rodriguez
LRLaura Rivino
Laura Rivino
JGJens Geginat
Jens Geginat
DJDavid Jarrossay
David Jarrossay
MGMarco Gattorno
Marco Gattorno
GNGiorgio Napolitani
Giorgio Napolitani

5 August 2007 in Nature Immunology
Verified
Journal Article
Closed access
EREva Acosta Rodriguez
Eva Acosta Rodriguez
GNGiorgio Napolitani
Giorgio Napolitani
ALAntonio Lanzavecchia
Antonio Lanzavecchia
FSFederica Sallusto
Federica Sallusto

7 April 2013 in Nature Immunology
Verified
Journal Article
Open access
PDF file
DBDaniela A Bermejo
Daniela A Bermejo
SJShaun W Jackson
Shaun W Jackson
MGMelisa Gorosito-Serran
Melisa Gorosito-Serran
EREva Acosta Rodriguez
Eva Acosta Rodriguez
MAMaria C Amezcua-Vesely
Maria C Amezcua-Vesely
DRDavid J Rawlings
David J Rawlings
Antibody production is the main effector function of B cells. Rawlings and colleagues show that Trypanosome cruzi induces rapid IL-17 production by B cells that is required for parasite control. Here we identified B cells as a major source of rapid, innate-like production of interleukin 17 (IL-17) in vivo in response to infection with Trypanosoma cruzi. IL-17+ B cells had a plasmablast phenotype, outnumbered cells of the TH17 subset of helper T cells and were required for an optimal response to this pathogen. With both mouse and human primary B cells, we found that exposure to parasite-derived trans-sialidase in vitro was sufficient to trigger modification of the cell-surface mucin CD45, which led to signaling dependent on the kinase Btk and production of IL-17A or IL-17F via a transcriptional program independent of the transcription factors RORγt and Ahr. Our combined data suggest that the generation of IL-17+ B cells may be a previously unappreciated feature of innate immune responses required for pathogen control or IL-17-mediated autoimmunity.

26 April 2012 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JBJimena Tosello Boari
Jimena Tosello Boari
MVMaría Carolina Amezcua Vesely
María Carolina Amezcua Vesely
DBDaniela Andrea Bermejo
Daniela Andrea Bermejo
MRMaria Cecilia Ramello
Maria Cecilia Ramello
CMCarolina Lucía Montes
Carolina Lucía Montes
EREva Acosta Rodriguez
Eva Acosta Rodriguez
Members of the IL-17 cytokine family play an important role in protection against pathogens through the induction of different effector mechanisms. We determined that IL-17A, IL-17E and IL-17F are produced during the acute phase of T. cruzi infection. Using IL-17RA knockout (KO) mice, we demonstrate that IL-17RA, the common receptor subunit for many IL-17 family members, is required for host resistance during T. cruzi infection. Furthermore, infected IL-17RA KO mice that lack of response to several IL-17 cytokines showed amplified inflammatory responses with exuberant IFN-γ and TNF production that promoted hepatic damage and mortality. Absence of IL-17RA during T. cruzi infection resulted in reduced CXCL1 and CXCL2 expression in spleen and liver and limited neutrophil recruitment. T. cruzi-stimulated neutrophils secreted IL-10 and showed an IL-10-dependent suppressive phenotype in vitro inhibiting T-cell proliferation and IFN-γ production. Specific depletion of Ly-6G+ neutrophils in vivo during T. cruzi infection raised parasitemia and serum IFN-γ concentration and resulted in increased liver pathology in WT mice and overwhelming wasting disease in IL-17RA KO mice. Adoptively transferred neutrophils were unable to migrate to tissues and to restore resistant phenotype in infected IL-17RA KO mice but migrated to spleen and liver of infected WT mice and downregulated IFN-γ production and increased survival in an IL-10 dependent manner. Our results underscore the role of IL-17RA in the modulation of IFN-γ-mediated inflammatory responses during infections and uncover a previously unrecognized regulatory mechanism that involves the IL-17RA-mediated recruitment of suppressive IL-10-producing neutrophils. IL-17 family is comprised for six members (IL-17A to F) that have been reported to play protective effects in bacterial and fungal infections and contradictory roles in parasite infections. Using mice deficient in IL-17RA, the common receptor subunit for many IL-17 family members, we determined that these cytokines are required for host protection against the parasite Trypanosoma cruzi. In absence of IL-17 signaling, mice developed an aggravated infection with similar levels of parasite in blood but increased inflammation and tissue damage of vital organs such as liver. We evaluated the mechanisms underlying this increased susceptibility and determined that the absence of IL-17RA caused a reduced arrival of neutrophils to organs such as spleen and liver. Neutrophils are phagocytic cells with abilities to directly destroy pathogens and also to regulate the inflammatory response. Indeed, we determined that neutrophils from T. cruzi infected mice are poisoned to secrete the regulatory cytokine IL-10. Finally, by experiments of depletion and adoptive transfer of neutrophils we determined that, during T. cruzi infection, IL-17RA is required for the recruitment of neutrophils that destroy the parasite and that also regulate inflammatory responses and collateral tissue damage by secreting IL-10.

29 April 2009 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
GNGiorgio Napolitani
Giorgio Napolitani
EREva Acosta Rodriguez
Eva Acosta Rodriguez
ALAntonio Lanzavecchia
Antonio Lanzavecchia
FSFederica Sallusto
Federica Sallusto
The contribution of Th1 and Th17 cells in chronic inflammatory conditions leading to autoimmunity remains highly controversial. In inflamed tissues, production of prostaglandins by COX‐2 has been proposed to favor Th17 responses indirectly by increasing IL‐23 and blocking IL‐12 release from APC. We report here that prostaglandin E2 (PGE2) can directly modulate cytokine production by human memory CD4+ T cells. TCR triggering in the presence of PGE2 increased IL‐17 and reduced IFN‐γ production by freshly isolated memory T cells or T‐cell clones. PGE2 triggered the EP2 and EP4 receptors expressed on T cells leading to a rapid increase of retinoic‐acid‐related orphan receptor‐γt (ROR‐γt) and decrease of T‐cell‐specific T‐box transcription factor 21 (T‐bet) mRNA. Moreover, PGE2 promoted the selective enrichment of IL‐17‐producing cells by differentially modulating the proliferation of memory T‐cell subsets in vitro. Taken together our results indicate that T‐cell effector function is a direct target for PGE2 modulation and suggest a novel mechanism by which inhibitors of prostaglandin synthesis, such as COX‐2 inhibitors, exert their anti‐inflammatory effect.

1 January 2004 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
EREva Acosta Rodriguez
Eva Acosta Rodriguez
CMCarolina L. Montes
Carolina L. Montes
CMClaudia C Motrán
Claudia C Motrán
EZElina I Zuniga
Elina I Zuniga
FLFu-Tong Liu
Fu-Tong Liu
AGAdriana Gruppi
Adriana Gruppi
The role of transcription factors in B cell survival and differentiation has been delineated during the last years. However, little is known about the intermediate signals and the intracellular pathways that control these events. In this study, we provide evidence both in vitro and in vivo, showing that galectin-3 (Gal-3), a β-galactoside-binding protein, is a critical mediator of B cell differentiation and survival. Although Gal-3 is not expressed in resting B cells from normal mice, its expression is markedly induced after activation with stimuli such as IL-4 and CD40 cross-linking. These signals promote survival and block the final differentiation of these cells, thus allowing the rising of a memory B cell phenotype. In addition, Gal-3 is expressed in B cells from Trypanosoma cruzi-infected mice, which received signals for activation and differentiation in vivo. By using an antisense strategy, we determined that Gal-3 is a critical signal mediating the effects of IL-4 on B cell fate. Blockade of intracellular Gal-3 in vitro abrogated IL-4-induced survival of activated B cells, favoring the differentiation toward a plasma cell pathway. Moreover, B cells with restrained endogenous Gal-3 expression failed to down-regulate the Blimp-1 transcription factor after IL-4 stimulation. Finally, inhibition of Gal-3 in vivo skewed the balance toward plasma cell differentiation, which resulted in increased Ig production and parasite clearance during T. cruzi infection. Thus, the present study provides evidence of a novel role for Gal-3 as an intracellular mediator of B cell survival and a checkpoint in IL-4-induced B cell commitment toward a memory phenotype.